Search results
Results from the WOW.Com Content Network
Abnormal uterine bleeding (AUB) in the reproductive years, unrelated to pregnancy, is rarely life-threatening, but is frequently life altering. The symptoms frequently interfere with quality of life and those girls and women affected by chronic AUB spend significant amounts of personal resources on menstrual products and medications.
Abnormal uterine bleeding (AUB), also known as atypical vaginal bleeding (AVB), is vaginal bleeding from the uterus that is abnormally frequent, lasts excessively long, is heavier than normal, or is irregular. [1] [3] The term dysfunctional uterine bleeding was used when no underlying cause was present. [3] Vaginal bleeding during pregnancy is ...
Heavy menstrual bleeding is defined as total menstrual flow >80ml per cycle, soaking a pad/tampon at least every 2 hours, changing a pad/tampon in the middle of the night, or bleeding lasting for >7 days. [3] [1] [9] Deviations in terms of frequency of menses, duration of menses, or volume of menses qualifies as abnormal uterine bleeding ...
Vaginal bleeding is any expulsion of blood from the vagina.This bleeding may originate from the uterus, vaginal wall, or cervix. [1] Generally, it is either part of a normal menstrual cycle or is caused by hormonal or other problems of the reproductive system, such as abnormal uterine bleeding.
Bleeding in excess of this norm in a nonpregnant woman constitutes gynecologic hemorrhage. In addition, early pregnancy bleeding has sometimes been included as gynecologic hemorrhage, namely bleeding from a miscarriage or an ectopic pregnancy, while it actually represents obstetrical bleeding. However, from a practical view, early pregnancy ...
Women who have abnormal bleeding after menopause typically undergo a non-invasive procedure — a transvaginal ultrasound — to look for signs of uterine cancer. But research suggests that test ...
FIGO System 1 for uterine bleeding. The system for definition and nomenclature of normal and abnormal uterine bleeding (AUB) in the reproductive years. In 2011, FIGO recognized two systems designed to aid research, education, and clinical care of women with abnormal uterine bleeding (AUB) in the reproductive years.
In the Novasure randomized controlled trial for FDA approval, the success rate (i.e. bleeding reduced to a normal or less level) was 78% and amenorrhea rate (i.e. bleeding eliminated) was 36%. The Minerva – Endometrial Ablation System, FDA approved in July 2015, is the first new FDA-approved surgical treatment for heavy menstrual bleeding in ...